# HCA Q3 2026 Earnings Report Highlights

> HCA Healthcare reports 3% same facility admissions growth with Medicaid supplement benefits rising to $600-800 million for 2026 amid payer mix shifts.
- Title: HCA Q3 2026 Earnings Report Highlights · The Motley Fool
- Summary: HCA Healthcare reports 3% same facility admissions growth with Medicaid supplement benefits rising to $600-800 million for 2026 amid payer mix shifts. HCA…
- Keywords: hca, q3 2026, earnings call, medicaid supplemental payments, payer mix, same facility admissions, adjusted ebitda, share repurchases, hospital capacity, finance, money, 2026
- Source: The Motley Fool — https://fool.com/earnings/call-transcripts/2026/10/27/hca-hca-q3-2026-earnings-call-transcript
- Author: Motley Fool Transcribing
- Published: 2026-10-27T17:54:23+00:00
- Read time: 1 min
- Topics: hca, q3 2026, earnings call, medicaid supplemental payments, payer mix, same facility admissions, adjusted ebitda, share repurchases, hospital capacity, finance, money
## Q3 2026 Results
HCA Healthcare reported 3% same facility admissions growth in Q3 2026.
## Revenue and Net Income
Revenue increased 3.6% to $19.849 billion, net income rose to $1.579 billion.
## Medicaid Supplemental Payments
Medicaid supplemental payments reached $50 million in Q3 2026, with full year 2026 estimate raised to $600-800 million.
## Payer Mix Impact
Payer mix shifts caused approximately $400 million unfavorable impact on adjusted EBITDA.
## Uninsured Volume
Uninsured volume accounted for 10.5% of total equivalent admissions in Q3 2026.
## Surgical Volumes
Inpatient surgeries declined 1.4%, outpatient surgeries dropped 3.7% in Q3 2026.
## Exchange Equivalent Admissions
Exchange equivalent admissions declined 19% year over year, improving 8% sequentially from Q2 2026.
## Capital Expenditures
Capital expenditures totaled $1.357 billion focused on hospital expansion and inpatient capacity.
## Share Repurchases
Share repurchases totaled $2.970 billion for 7.230 million shares in Q3 2026.
## 2027 Outlook
2027 volume growth forecasted at 2-3%, adjusted EBITDA expected to be consistent with 2026 levels.
## Medicaid Headwind
Medicaid supplemental payment net benefits expected to decline $550-650 million in 2027.
## Operational Costs
Same facility operating costs remained flat per equivalent admission excluding Medicaid programs.
## Professional Fees
Professional fees increased 12% year over year, driven by radiology and anesthesiology costs.
## 340B Program
HCA expects proposed Medicare OPPS rule to be a positive factor for 340B drug pricing.
## HICS Impact
HICS volumes declined 19% year over year, improving 8% sequentially from Q2 2026.
## 2027 Strategic Focus
HCA prioritizes digital transformation, network development, and caregiver environment improvements.
## Key takeaway

HCA Healthcare reported 3% same facility admissions growth in Q3 2026 with Medicaid supplemental payments expected to reach $600-800 million for 2026 despite payer mix headwinds.